Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ASTELLAS-PHARMA-INC-6491262/news/Astellas-Pharma-Affinivax-Reacquires-Rights-from-Astellas-for-ASP3772-a-Novel-24-valent-Streptoco-39617030/?utm_source=whatsapp&utm_medium=social&utm_campaign=share